✦ LIBER ✦

WS10.3 Adherence with ivacaftor in cystic fibrosis patients with the G551D mutation

✍ Scribed by Fox, J.; Jones, G.H.; Sapina-Vivo, R.; Phitidis, E.; Ledson, M.; Walshaw, M.; Greenwood, J.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Effects of ivacaftor on severely ill pat

✍ Hebestreit, Helge; Sauer-Heilborn, Annette; Fischer, Rainald; Käding, Manfred; M 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 481 KB

Ivacaftor treatment of cystic fibrosis p

✍ Kotha, K.; Clancy, J. P. 📂 Article 📅 2013 🏛 SAGE Publications 🌐 English ⚖ 775 KB

57 Ivacaftor in French patients with cys

✍ Hubert, D.; David, V.; Rault, G.; Dominique, S.; Mély, L.; Munck, A. 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 73 KB

WS6.5 Ivacaftor in subjects 6 to 11 year

✍ J.C. Davies; H. Li; K. Yen; R. Ahrens 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 68 KB

WS23.3 ICM is sensitive to detect potent

✍ Graeber, S.Y.; Hug, M.J.; Sommerburg, O.; Mainz, J.G.; Heinzmann, A.; Tümmler, B 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 61 KB

WS6.4 Long-term safety and efficacy of i

✍ E. McKone; H. Li; K. Yen; J.C. Davies 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 68 KB